Basit öğe kaydını göster

dc.contributor.authorGüngör, Serkan
dc.contributor.authorAsa, Sertaç
dc.contributor.authorKupik, Osman
dc.date.accessioned2020-12-19T19:50:24Z
dc.date.available2020-12-19T19:50:24Z
dc.date.issued2016
dc.identifier.citationGungor, S., Asa, S., Kupik, O. (2016). FDG PET/CT in peritoneal metastasis from prostate cancer. Clinical Nuclear Medicine, 41(9), E424-E425. https://doi.org/10.1097/RLU.0000000000001256en_US
dc.identifier.issn0363-9762
dc.identifier.issn1536-0229
dc.identifier.urihttps://doi.org/10.1097/RLU.0000000000001256
dc.identifier.urihttps://hdl.handle.net/11436/2426
dc.descriptionWOS: 000381315000009en_US
dc.descriptionPubMed: 27187732en_US
dc.description.abstractProstate cancer is one of the leading causes of cancer death in men. the prognosis in prostate cancer is greatly worsened by the presence of metastases, which are most commonly found in bone, lung, liver, and brain. the peritoneum is an extremely uncommon metastatic site for prostate cancer, even in autopsy series. We present a case of FDG PET/CT demonstration of peritoneal metastasis from prostate cancer.en_US
dc.language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectProstate canceren_US
dc.subjectPeritoneal metastasisen_US
dc.subjectF-18-FDG PET/CTen_US
dc.titleFDG PET/CT in peritoneal metastasis from prostate canceren_US
dc.typeeditorialen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorGüngör, Serkan
dc.contributor.institutionauthorAsa, Sertaç
dc.contributor.institutionauthorKupik, Osman
dc.identifier.doi10.1097/RLU.0000000000001256
dc.identifier.volume41en_US
dc.identifier.issue9en_US
dc.identifier.startpageE424en_US
dc.identifier.endpageE425en_US
dc.relation.journalClinical Nuclear Medicineen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster